News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
93 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19394)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (3)
2 (126)
3 (109)
4 (46)
5 (53)
6 (70)
7 (2)
8 (3)
9 (93)
10 (97)
11 (67)
12 (115)
13 (23)
16 (45)
17 (61)
18 (207)
19 (143)
20 (33)
21 (1)
22 (1)
23 (48)
24 (107)
25 (87)
26 (242)
27 (149)
29 (6)
30 (263)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
23
24
25
26
27
29
30
Biotech Bay
Kaiser Permanente Commits $2 Million to Gun Injury Prevention Research
New public health initiative to focus on preventing injuries and death from firearms
April 9, 2018
·
3 min read
Policy
FDA restricts sale and distribution of Essure to protect women and to require that patients receive risk information
The U.S. Food and Drug Administration today issued an order to restrict the sale and distribution of the Essure device to ensure that all women considering use of the permanent contraception device are provided with adequate risk information so that they can make informed decisions
April 9, 2018
·
6 min read
Citron Hygiene Launches New Website
As part of the overall rebranding initiative, Citron Hygiene is excited to announce the launch of its brand new, freshly redesigned website
April 9, 2018
·
1 min read
Business
CCA Industries, Inc. Announces Earnings Call and Loss for First Quarter 2018
CCA Industries, Inc. announced that it will be posting a loss for the first quarter of fiscal 2018. The Company will be issuing its first quarter 2018 results on Monday, April 16, 2018.
April 9, 2018
·
2 min read
Deals
In Second Gene Therapy Buy of the Year, Novartis Acquires AveXis for $8.7B
Novartis has struck a deal to acquire AveXis for $8.7 billion. Novartis will pay $218 per share, which is a 72 percent premium over AveXis’s 30-day volume-weighted average stock price.
April 9, 2018
·
3 min read
·
Mark
Drug Development
Merck’s Keytruda Grabs Another Late-Stage Clinical Win in Lung Cancer
Merck & Co. is chalking up another clinical win for its potent checkpoint inhibitor Keytruda. This morning the company announced the anti-PD-1 therapy hit its endpoints as a first-line monotherapy in lung cancer following an interim review of data.
April 9, 2018
·
2 min read
·
Alex Keown
Biotech Beach
Acadia Pharmaceuticals Plunges Following Report that Links Nuplazid to High Number of Deaths
Shares of Acadia Pharmaceuticals are down more than 18 percent in premarket trading following a CNN report that raises concerns over a number of deaths and adverse events linked to the company’s Parkinson’s disease drug Nuplazid.
April 9, 2018
·
2 min read
·
Alex Keown
Drug Development
Failed Clinical Trial: Menlo’s Stock Tanks
Menlo Therapeutics’ stock dropped 55 percent in premarket trading after announcing its serlopitant failed to meet primary and secondary endpoints in a Phase II clinical trial.
April 9, 2018
·
2 min read
·
Mark Terry
Doctor Calls for Alzheimer’s Boot Camps to Spur Drug Development
It’s no secret that drugmakers have struggled to develop a therapeutic to treat or halt the onset of Alzheimer’s disease. Multiple drugs have failed in late-stage trials and some companies, such as Pfizer, have largely given up on the space.
April 9, 2018
·
3 min read
·
Alex Keown
Drug Development
Constellation Raises $100M to Advance Several Clinical Trials
Constellation Pharmaceuticals closed on a financing round worth $100 million. The company plans to use the funds to advance several clinical trials.
April 9, 2018
·
2 min read
·
Mark Terry
Previous
9 of 10
Next